THE ECONOMIC CASE AGAINST THE DEATH TAX: STIFLING ENTREPRENEURSHIP

[JSM]

Health Issues
SOME INSURERS STOP WRITING NEW COVERAGE FOR KIDS

Ahead of an ObamaCare requirement to cover kids with medical problems,
some insurers drop out...

ASSOCIATED PRESS

Health Issues
BRITAIN PLANS TO DECENTRALIZE HEALTH CARE

Great Britain's new coalition government is proposing what would be
the largest reorganization of the country's government-run health care
system since its inception in 1948...

NEW YORK TIMES

Health Issues
AXE FALLS ON NHS SERVICES

Widespread cuts are planned across Great Britain's government-run
health care scheme, many of which have already been agreed by senior
health service officials; patients' groups have described the measures
as "astonishingly brutal"...

TELEGRAPH

Taxes
THE ECONOMIC CASE AGAINST THE DEATH TAX: STIFLING ENTREPRENEURSHIP

The death tax stands in the way of entrepreneurs, says economist
Curtis S. Dubay...

HERITAGE FOUNDATION

Health Issues
PUSH FOR MORE TRIALS MAY HURT PATIENTS

The Food and Drug Administration should negotiate cooperative
investigation agreements with foreign regulatory agencies and create a
better electronic registry for foreign trials, say Anup Malani, a
professor at the University of Chicago Law School, and Tomas J.
Philipson, the Daniel Levin professor of public policy at the
University of Chicago...

WASHINGTON EXAMINER

[gb]

On Mon, 26 Jul 2010 10:23:58 -0700 (PDT), JSM <ekrubmeg@**********>
wrote:

>Health Issues
>SOME INSURERS STOP WRITING NEW COVERAGE FOR KIDS
>
>Ahead of an ObamaCare requirement to cover kids with medical problems,
>some insurers drop out...
>
It always was about the money, and never about the kids, wasn't it

>Taxes
>THE ECONOMIC CASE AGAINST THE DEATH TAX: STIFLING ENTREPRENEURSHIP
>
>The death tax stands in the way of entrepreneurs, says economist
>Curtis S. Dubay...
>
>HERITAGE FOUNDATION

Nah -- it doesn't do that at all. It just keeps folks from inheriting
money they never earned.

>Health Issues
>PUSH FOR MORE TRIALS MAY HURT PATIENTS
>
>The Food and Drug Administration should negotiate cooperative
>investigation agreements with foreign regulatory agencies and create a
>better electronic registry for foreign trials, say Anup Malani, a
>professor at the University of Chicago Law School, and Tomas J.
>Philipson, the Daniel Levin professor of public policy at the
>University of Chicago...

Avandia.